Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2020 May 31;9(5):2149-2157.
doi: 10.4103/jfmpc.jfmpc_728_20. eCollection 2020 May.

Preventive and treatment strategies of COVID-19: From community to clinical trials

Kamal Kant Sahu  1 , Raman Kumar  2
Affiliations
Editorial

Preventive and treatment strategies of COVID-19: From community to clinical trials

Kamal Kant Sahu et al. J Family Med Prim Care. .

Abstract

The latest threat to global health is the form of the ongoing Coronavirus Disease 2019 (COVID-19) pandemic. This new coronavirus (SARS-COV-2) started as a local outbreak in Wuhan, China but soon tightened its grip on human lives around the globe. So far, we do not have a particularly effective anti-SARS-COV-2 vaccine or antiviral agent against COVID-19. Across the globe, many research organizations such as the National Institutes of Health (NIH), United States are studying and testing various drugs and vaccines for their effectiveness against SARS-COV-2. Currently, the principle fighting tool being promoted by the World Health Organization (WHO) is the prevention of acquiring SARS-COV-2 infection by following basic health hygiene rules and social distancing. We hereby discuss major non-pharmacological and pharmacological interventions.

Keywords: COVID-19; SARS-CoV-2; pandemic; quarantine; remdesivir; social distancing.

PubMed Disclaimer

Conflict of interest statement

There are no conflicts of interest.

Figures

Figure 1
Figure 1
Defining roles: Stepwise and integrative infrastructure to combat COVID-19
Figure 2
Figure 2
Stepwise approach of contact tracing for COVID-19
Figure 3
Figure 3
Modes of Transmission of SARS-CoV-2 infection (Part A), and what we can do as an Individual to stop transmission (Part B)
Figure 4
Figure 4
Schema to understand the impact of interventions on flattening the curve
Figure 5
Figure 5
Schema of management of patients, carriers depending on severity of illness
See this image and copyright information in PMC

References

    1. Sahu KK, Mishra AK, Lal A. COVID-2019: Update on epidemiology, disease spread and management. Monaldi Arch Chest Dis. 2020:90. doi: 104081/monaldi20201292. - PubMed
    1. Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical characteristics of coronavirus disease 2019 in China? N Engl J Med. 2020;382:1708–20. doi: 10.1056/NEJMoa2002032. - PMC - PubMed
    1. Gu J, Han B, Wang J. COVID-19: Gastrointestinal manifestations and potential fecal-oral transmission. Gastroenterology. 2020;158:1518–9. - PMC - PubMed
    1. Tian Y, Rong L, Nian W, He Y. Review article: Gastrointestinal features in COVID-19 and the possibility of faecal transmission. Aliment Pharmacol Ther. 2020;51:843–51. - PMC - PubMed
    1. Santarpia JL, Rivera DN, Herrera V, Morwitzer MJ, Creager H, Santarpia GW, et al. Transmission potential of SARS-CoV-2 in viral shedding observed at the University of Nebraska Medical Center. medRxiv. 2020 (published online Mar 26) doi: 101101/2020032320039446.

Publication types